DrugPatentWatch Database Preview
Amring Pharms Company Profile
What is the competitive landscape for AMRING PHARMS, and what generic and branded alternatives to AMRING PHARMS drugs are available?
AMRING PHARMS has ten approved drugs.
Summary for Amring Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
Drugs and US Patents for Amring Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amring Pharms | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | hydrocortisone; neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OTIC | 065216-001 | Oct 31, 2005 | DISCN | No | No | Start Trial | Start Trial | |||||
| Amring Pharms | MESALAMINE | mesalamine | SUPPOSITORY;RECTAL | 208362-001 | Jun 21, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Amring Pharms | ARSENIC TRIOXIDE | arsenic trioxide | INJECTABLE;INJECTION | 210802-001 | Nov 13, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
